Matches in SemOpenAlex for { <https://semopenalex.org/work/W2971836761> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2971836761 endingPage "100550" @default.
- W2971836761 startingPage "100550" @default.
- W2971836761 abstract "To report a case of dupilumab-associated blepharoconjunctivitis.A 48 year-old Caucasian male presented with bilateral blepharitis, multiple chalazia, dry eye disease and significant papillary conjunctivitis. The past medical history included fourteen years of severe atopic dermatitis. After failed attempts to treat atopic dermatitis with topical corticosteroids, the patient enrolled into a four-year clinical trial of biweekly dupilumab injections. Four to six weeks after initiation of dupilumab, the patient reported blurred vision, ocular irritation and redness. Slit lamp examination demonstrated bilateral meibomian gland dysfunction, edematous eyelids with multiple chalazia and significant papillary conjunctivitis. Meibography by Lipiscan revealed significant truncation, atrophy and bifurcation of meibomian glands bilaterally. The patient's multiple chalazia were excised and eyelid hygiene was closely followed. Cliradex wipes and Avenova were added to the patient's regime and one session of Lipiflow treatment was administered. The patient continued this eyelid hygiene regimen along with neomycin/polymyxin B/dexamethasone ophthalmic ointment after each dupilumab infusion.Five weeks after Lipiflow treatment with concomitant use of Cliradex and Avenova, visual acuity and ocular discomfort improved. Current treatment includes Cliradex eyelid wipes along with neomycin/polymyxin B/dexamethasone ophthalmic ointment for a week after each dupilumab infusion. Topical steroids and antibiotics with eyelid hygiene are effective ways to treat atopic dermatitis patients exhibiting dupilumab's ocular side effects. Lipiflow therapy may also help in treatment." @default.
- W2971836761 created "2019-09-12" @default.
- W2971836761 creator A5020858390 @default.
- W2971836761 creator A5068087656 @default.
- W2971836761 creator A5068964462 @default.
- W2971836761 creator A5053792983 @default.
- W2971836761 date "2019-12-01" @default.
- W2971836761 modified "2023-10-17" @default.
- W2971836761 title "Dupilumab-associated blepharoconjunctivitis" @default.
- W2971836761 cites W2174132185 @default.
- W2971836761 cites W2326526630 @default.
- W2971836761 cites W2399857417 @default.
- W2971836761 cites W2409293455 @default.
- W2971836761 cites W2524051065 @default.
- W2971836761 cites W2610814011 @default.
- W2971836761 cites W2681102259 @default.
- W2971836761 cites W2769186748 @default.
- W2971836761 cites W4237210808 @default.
- W2971836761 doi "https://doi.org/10.1016/j.ajoc.2019.100550" @default.
- W2971836761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6744522" @default.
- W2971836761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31535057" @default.
- W2971836761 hasPublicationYear "2019" @default.
- W2971836761 type Work @default.
- W2971836761 sameAs 2971836761 @default.
- W2971836761 citedByCount "18" @default.
- W2971836761 countsByYear W29718367612019 @default.
- W2971836761 countsByYear W29718367612020 @default.
- W2971836761 countsByYear W29718367612021 @default.
- W2971836761 countsByYear W29718367612022 @default.
- W2971836761 countsByYear W29718367612023 @default.
- W2971836761 crossrefType "journal-article" @default.
- W2971836761 hasAuthorship W2971836761A5020858390 @default.
- W2971836761 hasAuthorship W2971836761A5053792983 @default.
- W2971836761 hasAuthorship W2971836761A5068087656 @default.
- W2971836761 hasAuthorship W2971836761A5068964462 @default.
- W2971836761 hasBestOaLocation W29718367611 @default.
- W2971836761 hasConcept C141071460 @default.
- W2971836761 hasConcept C16005928 @default.
- W2971836761 hasConcept C2777165675 @default.
- W2971836761 hasConcept C2778329239 @default.
- W2971836761 hasConcept C2779159986 @default.
- W2971836761 hasConcept C2779824493 @default.
- W2971836761 hasConcept C2779884382 @default.
- W2971836761 hasConcept C2780238520 @default.
- W2971836761 hasConcept C2781302119 @default.
- W2971836761 hasConcept C54355233 @default.
- W2971836761 hasConcept C71924100 @default.
- W2971836761 hasConcept C86803240 @default.
- W2971836761 hasConceptScore W2971836761C141071460 @default.
- W2971836761 hasConceptScore W2971836761C16005928 @default.
- W2971836761 hasConceptScore W2971836761C2777165675 @default.
- W2971836761 hasConceptScore W2971836761C2778329239 @default.
- W2971836761 hasConceptScore W2971836761C2779159986 @default.
- W2971836761 hasConceptScore W2971836761C2779824493 @default.
- W2971836761 hasConceptScore W2971836761C2779884382 @default.
- W2971836761 hasConceptScore W2971836761C2780238520 @default.
- W2971836761 hasConceptScore W2971836761C2781302119 @default.
- W2971836761 hasConceptScore W2971836761C54355233 @default.
- W2971836761 hasConceptScore W2971836761C71924100 @default.
- W2971836761 hasConceptScore W2971836761C86803240 @default.
- W2971836761 hasLocation W29718367611 @default.
- W2971836761 hasLocation W29718367612 @default.
- W2971836761 hasLocation W29718367613 @default.
- W2971836761 hasLocation W29718367614 @default.
- W2971836761 hasLocation W29718367615 @default.
- W2971836761 hasOpenAccess W2971836761 @default.
- W2971836761 hasPrimaryLocation W29718367611 @default.
- W2971836761 hasRelatedWork W146157939 @default.
- W2971836761 hasRelatedWork W201137484 @default.
- W2971836761 hasRelatedWork W2044260571 @default.
- W2971836761 hasRelatedWork W2082837804 @default.
- W2971836761 hasRelatedWork W2351240173 @default.
- W2971836761 hasRelatedWork W2582847950 @default.
- W2971836761 hasRelatedWork W2992634005 @default.
- W2971836761 hasRelatedWork W3030381510 @default.
- W2971836761 hasRelatedWork W4231949408 @default.
- W2971836761 hasRelatedWork W4255827430 @default.
- W2971836761 hasVolume "16" @default.
- W2971836761 isParatext "false" @default.
- W2971836761 isRetracted "false" @default.
- W2971836761 magId "2971836761" @default.
- W2971836761 workType "article" @default.